Skip to site menu Skip to page content

Ypsomed is off to a Strong Start in 2026/27

CEO Simon Michel provides an update on Ypsomed's (SIX: YPSN) first quarter of fiscal year 2026/27. Thanks to new customer projects spanning many therapeutic areas, international recognition for its innovation,...

SpinScan Microarray Scanner

The SpinScan Microarray Scanner from Caduceus Biotechnology is based on a modified optical picking head, similar to well-established DVD technology, and tailored for the molecular diagnostic market. It is the...

[ajax_load_more container_type="div" css_classes="grid-x grid-padding-x" transition_container="false" post_type="pressreleases" images_loaded="true" posts_per_page="20" pause="true" offset="10" scroll="false" button_label="Load More Releases"]